Cargando…

Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study

BACKGROUND: Treatment indexes using continuous glucose monitoring (CGM) have become standardized internationally, and the use of ambulatory glucose profile (AGP) is currently recommended. However, the relationship between AGP indexes and standardized CGM metrics has not been investigated. Using flas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokutsu, Akemi, Okada, Yosuke, Torimoto, Keiichi, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424649/
https://www.ncbi.nlm.nih.gov/pubmed/32817761
http://dx.doi.org/10.1186/s13098-020-00577-5
_version_ 1783570374854705152
author Tokutsu, Akemi
Okada, Yosuke
Torimoto, Keiichi
Tanaka, Yoshiya
author_facet Tokutsu, Akemi
Okada, Yosuke
Torimoto, Keiichi
Tanaka, Yoshiya
author_sort Tokutsu, Akemi
collection PubMed
description BACKGROUND: Treatment indexes using continuous glucose monitoring (CGM) have become standardized internationally, and the use of ambulatory glucose profile (AGP) is currently recommended. However, the relationship between AGP indexes and standardized CGM metrics has not been investigated. Using flash glucose monitoring (FGM), this retrospective study served to evaluate the association of the inter-quartile range (IQR) of AGP with standardized CGM metrics. METHODS: The study subjects were 30 patients with type 2 diabetes mellitus (T2DM) and 23 non-diabetic patients (control group). We evaluated average IQR (AIQR) and standardized CGM metrics. The primary endpoint was the relationship between AIQR and Time in range (TIR) in a 24-h period. RESULTS: In the T2DM group, the AIQR was notably high and correlated negatively with TIR, and positively with Time above range, average interstitial glucose level, standard deviation of interstitial glucose, coefficient of variation of interstitial glucose, and mean of daily difference in blood glucose (MODD). For the T2DM group, the AIQR was notably lower in patients who achieved TIR > 70%, compared to those who did not. The AIQR cutoff value, as determined by ROC analysis, was 28.3 mg/dl for those who achieved TIR > 70%. No association was detected between the presence of hypoglycemia and AIQR. CONCLUSIONS: Our study is the first to provide the AIQR cutoff value for achieving the TIR target value. The range of interstitial glucose variability in AGP was associated with indexes of intra- and interday variations and hyperglycemia. Our results provide new perspectives in the yet-to-be established methods for evaluation of AGP in practical clinical settings.
format Online
Article
Text
id pubmed-7424649
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74246492020-08-16 Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study Tokutsu, Akemi Okada, Yosuke Torimoto, Keiichi Tanaka, Yoshiya Diabetol Metab Syndr Research BACKGROUND: Treatment indexes using continuous glucose monitoring (CGM) have become standardized internationally, and the use of ambulatory glucose profile (AGP) is currently recommended. However, the relationship between AGP indexes and standardized CGM metrics has not been investigated. Using flash glucose monitoring (FGM), this retrospective study served to evaluate the association of the inter-quartile range (IQR) of AGP with standardized CGM metrics. METHODS: The study subjects were 30 patients with type 2 diabetes mellitus (T2DM) and 23 non-diabetic patients (control group). We evaluated average IQR (AIQR) and standardized CGM metrics. The primary endpoint was the relationship between AIQR and Time in range (TIR) in a 24-h period. RESULTS: In the T2DM group, the AIQR was notably high and correlated negatively with TIR, and positively with Time above range, average interstitial glucose level, standard deviation of interstitial glucose, coefficient of variation of interstitial glucose, and mean of daily difference in blood glucose (MODD). For the T2DM group, the AIQR was notably lower in patients who achieved TIR > 70%, compared to those who did not. The AIQR cutoff value, as determined by ROC analysis, was 28.3 mg/dl for those who achieved TIR > 70%. No association was detected between the presence of hypoglycemia and AIQR. CONCLUSIONS: Our study is the first to provide the AIQR cutoff value for achieving the TIR target value. The range of interstitial glucose variability in AGP was associated with indexes of intra- and interday variations and hyperglycemia. Our results provide new perspectives in the yet-to-be established methods for evaluation of AGP in practical clinical settings. BioMed Central 2020-08-12 /pmc/articles/PMC7424649/ /pubmed/32817761 http://dx.doi.org/10.1186/s13098-020-00577-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tokutsu, Akemi
Okada, Yosuke
Torimoto, Keiichi
Tanaka, Yoshiya
Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study
title Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study
title_full Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study
title_fullStr Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study
title_full_unstemmed Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study
title_short Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study
title_sort relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424649/
https://www.ncbi.nlm.nih.gov/pubmed/32817761
http://dx.doi.org/10.1186/s13098-020-00577-5
work_keys_str_mv AT tokutsuakemi relationshipbetweeninterstitialglucosevariabilityinambulatoryglucoseprofileandstandardizedcontinuousglucosemonitoringmetricsapilotstudy
AT okadayosuke relationshipbetweeninterstitialglucosevariabilityinambulatoryglucoseprofileandstandardizedcontinuousglucosemonitoringmetricsapilotstudy
AT torimotokeiichi relationshipbetweeninterstitialglucosevariabilityinambulatoryglucoseprofileandstandardizedcontinuousglucosemonitoringmetricsapilotstudy
AT tanakayoshiya relationshipbetweeninterstitialglucosevariabilityinambulatoryglucoseprofileandstandardizedcontinuousglucosemonitoringmetricsapilotstudy